The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 24060 participants.

Also called NCT06953778

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 24,060 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06953778
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06953778. Randomized; no masking; primary purpose screening. Start 2027-03-08 (anticipated); primary completion 2032-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
Acronym
VALIANT-AF-S
Intervention (Device)
Zio XT® Patch
Lead sponsor
VA Office of Research and Development (class: US federal agency)

Record details

Record id
cardio:ct-nct06953778
Content hash
48420ccb14429ddac5defbb6e760cfbd1b1e081d179fe172ef2a9effc01afc99